Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529146 · ClinicalTrials.gov registry record
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
A clinical trial of Spinocerebellar Ataxias, sponsored by Biohaven Therapeutics.
- Active
- Registry status
- 909
- Enrollment target
- 1
- Study location
NCT06529146 is a study of Spinocerebellar Ataxias that is active but no longer recruiting, run by Biohaven Therapeutics. The registered enrollment target is 909 participants, above the 297-participant average among 5 other Spinocerebellar Ataxias trials with a reported enrollment target (206% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06529146, a study of Spinocerebellar Ataxias, is active but no longer recruiting, sponsored by Biohaven Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 909 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to leverage two sources of real-world data (RWD) to assess the effectiveness of troriluzole after three years of treatment in patients with SCA by comparison to an external control of untreated patients who were followed in a natural history cohort. Real world evidence of effectiveness will be assessed from the RWD sources to examine the treatment effects of toriluzole in SCA out to 3 years. Progression rates of SCA differ by genotype and long-term follow-up is needed to assess for potential efficacy in this rare disease.
Conditions Studied
Interventions
- DRUG BHV-4157
Study Locations (1)
Connecticut
- Biohaven - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 909 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06529146
The ClinicalTrials.gov registry entry for NCT06529146 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 909 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 5 other Spinocerebellar Ataxias trials with a reported enrollment target (206% higher). The listed sponsor is Biohaven Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinocerebellar Ataxias appearing as the primary indexed condition, and to 1 intervention - of which BHV-4157 is the first listed.
NCT06529146 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06529146 about?
NCT06529146 is a clinical study titled "Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control". The purpose of this study is to leverage two sources of real-world data (RWD) to assess the effectiveness of troriluzole after three years of treatment in patients with SCA by comparison to an external control of untreated patients who were followed in a natural history cohort. Real world evidence ...
What is the current status of trial NCT06529146?
This trial is currently active not recruiting. The enrollment target is 909 participants. The study started on 2019-03-18. Estimated completion is 2026-06.
What conditions does trial NCT06529146 study?
This clinical trial studies the following conditions: Spinocerebellar Ataxias.
What interventions are being tested in trial NCT06529146?
The interventions under investigation include: BHV-4157 (DRUG).
Who is sponsoring clinical trial NCT06529146?
This trial is sponsored by Biohaven Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529146 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinocerebellar Ataxias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
RECRUITING
-
Open Pilot Trial of BHV-4157
ACTIVE NOT RECRUITING · Phase 3
-
Troriluzole in Adult Participants With Spinocerebellar Ataxia
ACTIVE NOT RECRUITING · Phase 3
-
Aerobic Exercise, Balance Training, and Ataxia
COMPLETED · NA
-
Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.